 | • レポートコード：QYR9ST00308 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、神経栄養性角膜炎治療の世界市場について調査・分析し、神経栄養性角膜炎治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（防腐剤フリー人工涙液、局所抗生物質、タラソラフィー、羊膜移植、包帯コンタクトレンズ、組換えヒト神経成長因子）、用途別（病院、外来手術センター、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の神経栄養性角膜炎治療市場動向 ・主要企業別マーケットシェア ・神経栄養性角膜炎治療の種類別市場規模2014-2019 （防腐剤フリー人工涙液、局所抗生物質、タラソラフィー、羊膜移植、包帯コンタクトレンズ、組換えヒト神経成長因子） ・神経栄養性角膜炎治療の用途別市場規模2014-2019 （病院、外来手術センター、その他） ・神経栄養性角膜炎治療の北米市場：主要企業・種類別/用途別市場規模 ・神経栄養性角膜炎治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・神経栄養性角膜炎治療の中国市場：主要企業・種類別/用途別市場規模 ・神経栄養性角膜炎治療の日本国内市場：主要企業・種類別/用途別市場規模 ・神経栄養性角膜炎治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・神経栄養性角膜炎治療のインド市場：主要企業・種類別/用途別市場規模 ・神経栄養性角膜炎治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Allergan, Plc.、Abbott Laboratories, Inc.、Bausch & Lomb Incorporated、Bayer AG、CooperVision、Dompe farmaceutici S.p.A.、Johnson & Johnson、Novartis AG、ReGenTree, LLC.、Walgreens） ・神経栄養性角膜炎治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Neurotrophic keratitis is an orphan disease with a global prevalence rate of 5 per 10,000 people. It is manifested by the damage of trigeminal nucleus nerve innervations present in the eye corneal region which dampens the healing process of corneal injuries. The treatment approach is adopted as per the different stages of the disease.In 2018, the global Neurotrophic Keratitis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Neurotrophic Keratitis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Neurotrophic Keratitis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Allergan, Plc.
Abbott Laboratories, Inc.
Bausch & Lomb Incorporated
Bayer AG
CooperVision
Dompe farmaceutici S.p.A.
Johnson & Johnson
Novartis AG
ReGenTree, LLC.
Walgreens
Market segment by Type, the product can be split into
Preservative Free Artificial Tears
Topical Antibiotics
Tarsorraphy
Amniotic Membrane Transplantation
Bandage Contact Lenses
Recombinant Human Nerve Growth Factor
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Neurotrophic Keratitis Treatment status, future forecast, growth opportunity, key market and key players.
To present the Neurotrophic Keratitis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Neurotrophic Keratitis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Neurotrophic Keratitis Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Preservative Free Artificial Tears
1.4.3 Topical Antibiotics
1.4.4 Tarsorraphy
1.4.5 Amniotic Membrane Transplantation
1.4.6 Bandage Contact Lenses
1.4.7 Recombinant Human Nerve Growth Factor
1.5 Market by Application
1.5.1 Global Neurotrophic Keratitis Treatment Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Neurotrophic Keratitis Treatment Market Size
2.2 Neurotrophic Keratitis Treatment Growth Trends by Regions
2.2.1 Neurotrophic Keratitis Treatment Market Size by Regions (2019-2025)
2.2.2 Neurotrophic Keratitis Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Neurotrophic Keratitis Treatment Market Size by by Players
3.1.1 Global Neurotrophic Keratitis Treatment Revenue by by Players (2014-2019)
3.1.2 Global Neurotrophic Keratitis Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Neurotrophic Keratitis Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Neurotrophic Keratitis Treatment Key Players Head office and Area Served
3.3 Key Players Neurotrophic Keratitis Treatment Product/Solution/Service
3.4 Date of Enter into Neurotrophic Keratitis Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Neurotrophic Keratitis Treatment Market Size by Type (2014-2019)
4.2 Global Neurotrophic Keratitis Treatment Market Size by Application (2014-2019)
5 North America
5.1 North America Neurotrophic Keratitis Treatment Market Size (2014-2019)
5.2 Neurotrophic Keratitis Treatment Key Players in North America
5.3 North America Neurotrophic Keratitis Treatment Market Size by Type
5.4 North America Neurotrophic Keratitis Treatment Market Size by Application
6 Europe
6.1 Europe Neurotrophic Keratitis Treatment Market Size (2014-2019)
6.2 Neurotrophic Keratitis Treatment Key Players in Europe
6.3 Europe Neurotrophic Keratitis Treatment Market Size by Type
6.4 Europe Neurotrophic Keratitis Treatment Market Size by Application
7 China
7.1 China Neurotrophic Keratitis Treatment Market Size (2014-2019)
7.2 Neurotrophic Keratitis Treatment Key Players in China
7.3 China Neurotrophic Keratitis Treatment Market Size by Type
7.4 China Neurotrophic Keratitis Treatment Market Size by Application
8 Japan
8.1 Japan Neurotrophic Keratitis Treatment Market Size (2014-2019)
8.2 Neurotrophic Keratitis Treatment Key Players in Japan
8.3 Japan Neurotrophic Keratitis Treatment Market Size by Type
8.4 Japan Neurotrophic Keratitis Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Neurotrophic Keratitis Treatment Market Size (2014-2019)
9.2 Neurotrophic Keratitis Treatment Key Players in Southeast Asia
9.3 Southeast Asia Neurotrophic Keratitis Treatment Market Size by Type
9.4 Southeast Asia Neurotrophic Keratitis Treatment Market Size by Application
10 India
10.1 India Neurotrophic Keratitis Treatment Market Size (2014-2019)
10.2 Neurotrophic Keratitis Treatment Key Players in India
10.3 India Neurotrophic Keratitis Treatment Market Size by Type
10.4 India Neurotrophic Keratitis Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Neurotrophic Keratitis Treatment Market Size (2014-2019)
11.2 Neurotrophic Keratitis Treatment Key Players in Central & South America
11.3 Central & South America Neurotrophic Keratitis Treatment Market Size by Type
11.4 Central & South America Neurotrophic Keratitis Treatment Market Size by Application
12 International Players Profiles
12.1 Allergan, Plc.
12.1.1 Allergan, Plc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Neurotrophic Keratitis Treatment Introduction
12.1.4 Allergan, Plc. Revenue in Neurotrophic Keratitis Treatment Business (2014-2019))
12.1.5 Allergan, Plc. Recent Development
12.2 Abbott Laboratories, Inc.
12.2.1 Abbott Laboratories, Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Neurotrophic Keratitis Treatment Introduction
12.2.4 Abbott Laboratories, Inc. Revenue in Neurotrophic Keratitis Treatment Business (2014-2019)
12.2.5 Abbott Laboratories, Inc. Recent Development
12.3 Bausch & Lomb Incorporated
12.3.1 Bausch & Lomb Incorporated Company Details
12.3.2 Company Description and Business Overview
12.3.3 Neurotrophic Keratitis Treatment Introduction
12.3.4 Bausch & Lomb Incorporated Revenue in Neurotrophic Keratitis Treatment Business (2014-2019)
12.3.5 Bausch & Lomb Incorporated Recent Development
12.4 Bayer AG
12.4.1 Bayer AG Company Details
12.4.2 Company Description and Business Overview
12.4.3 Neurotrophic Keratitis Treatment Introduction
12.4.4 Bayer AG Revenue in Neurotrophic Keratitis Treatment Business (2014-2019)
12.4.5 Bayer AG Recent Development
12.5 CooperVision
12.5.1 CooperVision Company Details
12.5.2 Company Description and Business Overview
12.5.3 Neurotrophic Keratitis Treatment Introduction
12.5.4 CooperVision Revenue in Neurotrophic Keratitis Treatment Business (2014-2019)
12.5.5 CooperVision Recent Development
12.6 Dompe farmaceutici S.p.A.
12.6.1 Dompe farmaceutici S.p.A. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Neurotrophic Keratitis Treatment Introduction
12.6.4 Dompe farmaceutici S.p.A. Revenue in Neurotrophic Keratitis Treatment Business (2014-2019)
12.6.5 Dompe farmaceutici S.p.A. Recent Development
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Company Details
12.7.2 Company Description and Business Overview
12.7.3 Neurotrophic Keratitis Treatment Introduction
12.7.4 Johnson & Johnson Revenue in Neurotrophic Keratitis Treatment Business (2014-2019)
12.7.5 Johnson & Johnson Recent Development
12.8 Novartis AG
12.8.1 Novartis AG Company Details
12.8.2 Company Description and Business Overview
12.8.3 Neurotrophic Keratitis Treatment Introduction
12.8.4 Novartis AG Revenue in Neurotrophic Keratitis Treatment Business (2014-2019)
12.8.5 Novartis AG Recent Development
12.9 ReGenTree, LLC.
12.9.1 ReGenTree, LLC. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Neurotrophic Keratitis Treatment Introduction
12.9.4 ReGenTree, LLC. Revenue in Neurotrophic Keratitis Treatment Business (2014-2019)
12.9.5 ReGenTree, LLC. Recent Development
12.10 Walgreens
12.10.1 Walgreens Company Details
12.10.2 Company Description and Business Overview
12.10.3 Neurotrophic Keratitis Treatment Introduction
12.10.4 Walgreens Revenue in Neurotrophic Keratitis Treatment Business (2014-2019)
12.10.5 Walgreens Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Neurotrophic Keratitis Treatment Key Market Segments
Table Key Players Neurotrophic Keratitis Treatment Covered
Table Global Neurotrophic Keratitis Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Preservative Free Artificial Tears Figures
Table Key Players of Preservative Free Artificial Tears
Figuer Topical Antibiotics Figures
Table Key Players of Topical Antibiotics
Figuer Tarsorraphy Figures
Table Key Players of Tarsorraphy
Figuer Amniotic Membrane Transplantation Figures
Table Key Players of Amniotic Membrane Transplantation
Figuer Bandage Contact Lenses Figures
Table Key Players of Bandage Contact Lenses
Figuer Recombinant Human Nerve Growth Factor Figures
Table Key Players of Recombinant Human Nerve Growth Factor
Table Global Neurotrophic Keratitis Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Neurotrophic Keratitis Treatment Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Others Case Studies
Figure Neurotrophic Keratitis Treatment Report Years Considered
Figure Global Neurotrophic Keratitis Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Neurotrophic Keratitis Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Neurotrophic Keratitis Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Neurotrophic Keratitis Treatment Market Share by Regions 2014-2019
Figure Global Neurotrophic Keratitis Treatment Market Share by Regions 2014-2019
Figure Global Neurotrophic Keratitis Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Neurotrophic Keratitis Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Neurotrophic Keratitis Treatment Market Share by by Players (2014-2019)
Figure Global Neurotrophic Keratitis Treatment Market Share by by Players in 2018
Table Global Neurotrophic Keratitis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Neurotrophic Keratitis Treatment Product/Solution/Service
Table Date of Enter into Neurotrophic Keratitis Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Neurotrophic Keratitis Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Neurotrophic Keratitis Treatment Market Size Share by Type (2014-2019)
Figure Global Neurotrophic Keratitis Treatment Market Size Market Share by Type (2014-2019)
Table Global Neurotrophic Keratitis Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Neurotrophic Keratitis Treatment Market Size Share by Application (2014-2019)
Figure Global Neurotrophic Keratitis Treatment Market Size Market Share by Application (2014-2019)
Figure Global Neurotrophic Keratitis Treatment Revenue Market Share by Application in 2018
Figure North America Neurotrophic Keratitis Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Neurotrophic Keratitis Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Neurotrophic Keratitis Treatment Market Share (2018-2019)
Table North America Neurotrophic Keratitis Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Neurotrophic Keratitis Treatment Market Share by Type 2014-2019
Table North America Neurotrophic Keratitis Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Neurotrophic Keratitis Treatment Market Share by Application 2014-2019
Figure Europe Neurotrophic Keratitis Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Neurotrophic Keratitis Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Neurotrophic Keratitis Treatment Market Share (2018-2019)
Table Europe Neurotrophic Keratitis Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Neurotrophic Keratitis Treatment Market Share by Type 2014-2019
Table Europe Neurotrophic Keratitis Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Neurotrophic Keratitis Treatment Market Share by Application 2014-2019
Figure China Neurotrophic Keratitis Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Neurotrophic Keratitis Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Neurotrophic Keratitis Treatment Market Share (2018-2019)
Table China Neurotrophic Keratitis Treatment Market Size by Type 2014-2019 (Million US$)
Table China Neurotrophic Keratitis Treatment Market Share by Type 2014-2019
Table China Neurotrophic Keratitis Treatment Market Size by Application 2014-2019 (Million US$)
Table China Neurotrophic Keratitis Treatment Market Share by Application 2014-2019
Figure Japan Neurotrophic Keratitis Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Neurotrophic Keratitis Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Neurotrophic Keratitis Treatment Market Share (2018-2019)
Table Japan Neurotrophic Keratitis Treatment Market Size by Type 2014-2019 (Million US$)
Table Japan Neurotrophic Keratitis Treatment Market Share by Type 2014-2019
Table Japan Neurotrophic Keratitis Treatment Market Size by Application 2014-2019 (Million US$)
Table Japan Neurotrophic Keratitis Treatment Market Share by Application 2014-2019
Figure Southeast Asia Neurotrophic Keratitis Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Neurotrophic Keratitis Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Neurotrophic Keratitis Treatment Market Share (2018-2019)
Table Southeast Asia Neurotrophic Keratitis Treatment Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Neurotrophic Keratitis Treatment Market Share by Type 2014-2019
Table Southeast Asia Neurotrophic Keratitis Treatment Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Neurotrophic Keratitis Treatment Market Share by Application 2014-2019
Figure India Neurotrophic Keratitis Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Neurotrophic Keratitis Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Neurotrophic Keratitis Treatment Market Share (2018-2019)
Table India Neurotrophic Keratitis Treatment Market Size by Type 2014-2019 (Million US$)
Table India Neurotrophic Keratitis Treatment Market Share by Type 2014-2019
Table India Neurotrophic Keratitis Treatment Market Size by Application 2014-2019 (Million US$)
Table India Neurotrophic Keratitis Treatment Market Share by Application 2014-2019
Figure Central & South America Neurotrophic Keratitis Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Neurotrophic Keratitis Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Neurotrophic Keratitis Treatment Market Share (2018-2019)
Table Central & South America Neurotrophic Keratitis Treatment Market Size by Type 2014-2019 (Million US$)
Table Central & South America Neurotrophic Keratitis Treatment Market Share by Type 2014-2019
Table Central & South America Neurotrophic Keratitis Treatment Market Size by Application 2014-2019 (Million US$)
Table Central & South America Neurotrophic Keratitis Treatment Market Share by Application 2014-2019
Table Allergan, Plc. Company Details
Table Allergan, Plc. Revenue in Neurotrophic Keratitis Treatment Business 2014-2019 (Million US$)
Figure Allergan, Plc. Revenue Growth Rate in Neurotrophic Keratitis Treatment Business (2014-2019)
Table Allergan, Plc. Recent Development
Table Abbott Laboratories, Inc. Company Details
Table Abbott Laboratories, Inc. Revenue in Neurotrophic Keratitis Treatment Business 2014-2019 (Million US$)
Figure Abbott Laboratories, Inc. Revenue Growth Rate in Neurotrophic Keratitis Treatment Business (2014-2019)
Table Abbott Laboratories, Inc. Recent Development
Table Bausch & Lomb Incorporated Company Details
Table Bausch & Lomb Incorporated Revenue in Neurotrophic Keratitis Treatment Business 2014-2019 (Million US$)
Figure Bausch & Lomb Incorporated Revenue Growth Rate in Neurotrophic Keratitis Treatment Business (2014-2019)
Table Bausch & Lomb Incorporated Recent Development
Table Bayer AG Company Details
Table Bayer AG Revenue in Neurotrophic Keratitis Treatment Business 2014-2019 (Million US$)
Figure Bayer AG Revenue Growth Rate in Neurotrophic Keratitis Treatment Business (2014-2019)
Table Bayer AG Recent Development
Table CooperVision Company Details
Table CooperVision Revenue in Neurotrophic Keratitis Treatment Business 2014-2019 (Million US$)
Figure CooperVision Revenue Growth Rate in Neurotrophic Keratitis Treatment Business (2014-2019)
Table CooperVision Recent Development
Table Dompe farmaceutici S.p.A. Company Details
Table Dompe farmaceutici S.p.A. Revenue in Neurotrophic Keratitis Treatment Business 2014-2019 (Million US$)
Figure Dompe farmaceutici S.p.A. Revenue Growth Rate in Neurotrophic Keratitis Treatment Business (2014-2019)
Table Dompe farmaceutici S.p.A. Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Neurotrophic Keratitis Treatment Business 2014-2019 (Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Neurotrophic Keratitis Treatment Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Neurotrophic Keratitis Treatment Business 2014-2019 (Million US$)
Figure Novartis AG Revenue Growth Rate in Neurotrophic Keratitis Treatment Business (2014-2019)
Table Novartis AG Recent Development
Table ReGenTree, LLC. Company Details
Table ReGenTree, LLC. Revenue in Neurotrophic Keratitis Treatment Business 2014-2019 (Million US$)
Figure ReGenTree, LLC. Revenue Growth Rate in Neurotrophic Keratitis Treatment Business (2014-2019)
Table ReGenTree, LLC. Recent Development
Table Walgreens Company Details
Table Walgreens Revenue in Neurotrophic Keratitis Treatment Business 2014-2019 (Million US$)
Figure Walgreens Revenue Growth Rate in Neurotrophic Keratitis Treatment Business (2014-2019)
Table Walgreens Recent Development
Table Global Neurotrophic Keratitis Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Neurotrophic Keratitis Treatment Market Size Share by Regions (2019-2025)
Figure Global Neurotrophic Keratitis Treatment Market Size Share by Regions in 2025
Figure North America Neurotrophic Keratitis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Neurotrophic Keratitis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Neurotrophic Keratitis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Neurotrophic Keratitis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Neurotrophic Keratitis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Neurotrophic Keratitis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Neurotrophic Keratitis Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Neurotrophic Keratitis Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Neurotrophic Keratitis Treatment Market Size by Product (2019-2025)
Figure Global Neurotrophic Keratitis Treatment Market Size by Product in 2025
Table Global Neurotrophic Keratitis Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Neurotrophic Keratitis Treatment Market Size by Application (2019-2025)
Figure Global Neurotrophic Keratitis Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
因子IX欠乏症の治療の世界市場：市場規模・現状・予測 Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B.In this market study, analysts have estimated the prophylaxis segment to dominate the factor IX deficiency treatment market duri…- 世界の人工涙市場：専門的調査 Artificial tears are lubricant eye drops used to treat the dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations.In consumption market, the growth rate of global consumption is s…
- 尺骨神経の治療の世界市場：市場規模・現状・予測 Ulnar nerve runs all the way form the shoulder to the little finger. This nerve manages the muscles that allow humans to make movements with the finger. As the ulnar nerve isn't protected by muscle or bones chance of damage to the nerve is common. Globally North America is a major market for ulnar n…
- 第VIII因子欠乏症の治療の世界市場：市場規模・現状・予測 Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is generated in liver sinusoidal cells and endotheli…
- 血友病A及びB組換え因子補充療法の世界市場：市場規模・現状・予測 Haemophilia is a group of inherited genetic disorders which causes abnormal or exaggerated bleeding. It impairs the normal mechanism of blood clotting after an injury. Internal bleeding inside the joint or inside brain is commonly seen in the patients with severe to moderate haemophilia. Its symptom…